ASHLEY CAREY: Open Payments
NPI 1184244667 · GENEVA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$648 in 30 payments from 10 companies in 2025. Trend: 2023 $490 · 2024 $496 · 2025 $648
Food & beverage: $648
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $118 |
| Novartis Pharmaceuticals Corporation | 5 | $117 |
| PFIZER INC. | 4 | $74 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Novo Nordisk Inc | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47 |
| Alnylam Pharmaceuticals Inc. | 2 | $43 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $41 |
| BridgeBio Pharma, Inc. | 2 | $39 |
Products named: REPATHA, LEQVIO, ELIQUIS, Wegovy, BRILINTA, JARDIANCE, ONPATTRO, LifeVest.
Industry payments across OH — which companies pay providers there.
